Immunotherapy Clinical Trials

0 recruiting

Showing 117 of 17 trials

Recruiting

To Conduct Multi-omics Integrated Studies in Peripheral Blood, Such as Fragment Omics, Metabolomics and Epigenetics, and Establish Non-invasive Dynamic Follow-up Monitoring Programs During Perioperative and Postoperative Periods (Observational Study)

Neoadjuvant TherapyLung NeoplasmsMinimal Residual Disease+1 more
Peking University People's Hospital100 enrolled1 locationNCT07291921
Recruiting
Phase 2

The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer

NSCLCImmunotherapyStereotactic Body Radiation Therapy (SBRT)
Fudan University27 enrolled1 locationNCT06738160
Recruiting

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies

CancerBladder CancerImmunotherapy+1 more
Elephas2,000 enrolled8 locationsNCT07327489
Recruiting

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform

CancerBladder CancerKidney Cancer+3 more
Elephas416 enrolled12 locationsNCT05520099
Recruiting
Phase 1

VSV-02 Compassionate Use in Advanced Solid Tumors

Breast CancerLung CancerMelanoma+3 more
The First Affiliated Hospital of Xinxiang Medical College6 enrolled1 locationNCT07260591
Recruiting
Not Applicable

Evaluating a Fasting-mimicking Diet in Combination With Immunotherapy in Patients With Non-small Cell Lung Cancer

NSCLCImmunotherapyStage IV NSCLC+1 more
VA Office of Research and Development66 enrolled4 locationsNCT06671613
Recruiting
Phase 3

Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer

Neoadjuvant TherapyImmunotherapyLocally Advanced Non-Small Cell Lung Cancer+1 more
Sun Yat-sen University497 enrolled1 locationNCT06734702
Recruiting

Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)

ImmunotherapySmall Cell Lung CancerBiomarkers+3 more
Oncology Center of Biochemical Education And Research111 enrolled2 locationsNCT06717243
Recruiting

A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLC

NSCLCImmunotherapyLung Diseases, Interstitial
Universitaire Ziekenhuizen KU Leuven70 enrolled1 locationNCT04807114
Recruiting
Phase 1

GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression

Hepatocellular CarcinomaImmunotherapySquamous Cell Lung Cancer+3 more
Second Affiliated Hospital of Guangzhou Medical University30 enrolled2 locationsNCT03198546
Recruiting
Phase 1

GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T Cells Against Cancers

Lung CancerCancerImmunotherapy+1 more
Second Affiliated Hospital of Guangzhou Medical University30 enrolled2 locationsNCT03198052
Recruiting
Phase 2

Pembrolizumab Plus Bevacizumab and Chemotherapy for ALK-rearranged NSCLC With Persistent 5'ALK

Lung AdenocarcinomaImmunotherapyALK Gene Mutation
Hunan Province Tumor Hospital78 enrolled1 locationNCT05266846
Recruiting
Not Applicable

Primary Tumor Radiotherapy Omitting CTV for Patients With Advanced NSCLC Responded to Immunotherapy and Chemotherapy

RadiotherapyImmunotherapyAdvanced Non-Small Cell Squamous Lung Cancer
Hubei Cancer Hospital134 enrolled1 locationNCT06037733
Recruiting
Phase 2

Stereotactic Radiotherapy Combined With Adebrelimab and TCb (Nab-paclitaxel + Carboplatin) in Neoadjuvant Treatment of TNBC

Breast CancerImmunotherapyStereotactic Radiotherapy
Shengjing Hospital136 enrolled1 locationNCT06165900
Recruiting
Phase 2

Neoadjuvant Triprizumab and Radiotherapy in Operable Patients With Stage IIA-IIIA Non-small Cell Lung Cancer

Neoadjuvant TherapyNon-small Cell Lung CancerRadiotherapy+1 more
Northern Jiangsu People's Hospital20 enrolled1 locationNCT06065813
Recruiting
Phase 2

Adjuvant Chemotherapy Combined With Camrelizumab for ⅡA -ⅢA NSCLC Patients

ChemotherapyImmunotherapy
Nanfang Hospital, Southern Medical University57 enrolled1 locationNCT05825443
Recruiting

The Real World Study of Neoadjuvant Immunotherapy in Early Stage NSCLC in China

Lung CancerImmunotherapy
Guangdong Association of Clinical Trials100 enrolled1 locationNCT04286841